$CRBU Cashflow Statement | Understand Stock

$CRBU

$0.46 -$0.03 (6.4%) Close

$CRBU Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Gain on disposal of fixed assets
Impairment charges
Impairment Of Equity Method Investment
Non-cash consideration for licensing and collaboration revenue
Change in fair value of equity securities
Stock-based compensation expense
Initial fair value of MSKCC success payments liability
Change in fair value of MSKCC success payments liability
Acquired in-process research and development
Extinguishment of PPP Loan and accrued interest
Accretion of discounts on investments in marketable securities, net
Non-cash lease expense

Changes in operating assets and liabilities:
Accounts receivable
Contract assets
Other receivables
Prepaid expenses and other current assets
Other assets
Accounts payable
Accrued expenses and other current liabilities
Deferred revenue, current and long-term
Deferred rent and lease incentive liability
Operating lease liabilities
Other liabilities
Deferred tax liabilities

Net cash used in operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Maturities of marketable securities
Proceeds from maturities of marketable securities
Purchases of marketable securities
Purchases of property and equipment
Proceeds from sale of property and equipment
Payments to acquire in-process research and development
Net cash provided by investing activities

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from initial public offering of common stock, net of offering costs
Proceeds from issuance of Series C convertible preferred stock, net of issuance costs
Proceeds from follow-on public offering, net of offering expenses
Proceeds from Issuance of Private Placement
Proceeds from exercise of stock options
Repayment of promissory note
Proceeds from PPP Loan
Payments on capital lease
Proceeds from issuances of common stock under ESPP
Proceeds from issuances of common stock related to ATM, net of offering expenses
Net cash provided by financing activities

NET DECREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH
CASH AND CASH EQUIVALENTS —End of period
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH — BEGINNING OF PERIOD
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH — END OF PERIOD
Cash paid for income taxes
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Purchases of property and equipment included in accounts payable and accrued expenses
Capital lease financing for purchase of assets
Extinguishment of PPP Loan and accrued interest
Non-cash consideration in exchange for licensing and collaboration revenue
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Conversion of convertible preferred stock to common stock at closing of initial public offering

RECONCILIATION OF CASH, CASH EQUIVALENTS, AND RESTRICTED CASH
Cash and cash equivalents
Restricted cash

Comments